Optimizing QACT Frequency in Proton Therapy: Analysis of Standard Guidelines Across Treatment Sites
Authors:
Open Access
- 25 September 2025
- journal article
- Published by Elsevier in International Journal of Particle Therapy
- Vol. 18, 101205
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Institutes of Health National Cancer Institute (U54CA295336)
This publication has 21 references indexed in Scilit:
- The influence of daily imaging and target margin reduction on secondary cancer risk in image-guided and adaptive proton therapyPhysics in Medicine & Biology, 2024
- Synthetic CT generation from CBCT based on structural constraint cycle-EEM-GANBiomedical Physics & Engineering Express, 2024
- Use of CBCT plus plan robustness for reducing QACT frequency in intensity‐modulated proton therapy: Head‐and‐neck casesMedical Physics, 2022
- Improving cone-beam CT quality using a cycle-residual connection with a dilated convolution-consistent generative adversarial networkPhysics in Medicine & Biology, 2022
- Dosimetric evaluation of cone‐beam CT‐based synthetic CTs in pediatric patients undergoing intensity‐modulated proton therapyJournal of Applied Clinical Medical Physics, 2022
- Cone-beam CT image quality improvement using Cycle-Deblur consistent adversarial networks (Cycle-Deblur GAN) for chest CT imaging in breast cancer patientsScientific Reports, 2021
- CBCT correction using a cycle-consistent generative adversarial network and unpaired training to enable photon and proton dose calculationPhysics in Medicine & Biology, 2019
- A comprehensive evaluation of the accuracy of CBCT and deformable registration based dose calculation in lung proton therapyBiomedical Physics & Engineering Express, 2017
- A Multidisciplinary Orbit-Sparing Treatment Approach That Includes Proton Therapy for Epithelial Tumors of the Orbit and Ocular AdnexaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2015
- Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non–small-cell lung cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006